Parabolic Drugs IPO : Opening on 14th June 2010

by khalid on 10/06/2010 · 0 comments

Parabolic Drugs engaged in the manufacturing, including contract manufacturing, of APIs and API intermediates for the domestic market as well as for exports to international markets. The company is entering in the Indian capital market with the issue size of Rs 200 crore. The IPO is opening on 14th June 2010 and the shares will be available for subscription up to 17th June 2010. The premium of the issue will be decided through a 100% Book Building Process. The price band for the issue is yet to be fixed by the company.

The proceeds of the IPO will be used by the company for its multi-purpose block III at Derabassi; Sterile cephalosporin plant at Derabassi; establishment of Chachrauli plant; custom synthesis & manufacturing site II at IT Park, Panchkula and repayment / prepayment of identified loan facilities.

The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Issue Detail:-
Issue Open : 14th Junel 2010 – 17th June 2010
Issue Type : 100% Book Built Issue IPO
Issue Size : Rs 200 crores
Face Value : Rs 10 Per Equity Share
Issue Price : Rs. 75 – Rs. 85 per share
Market Lot : 80 shares
Minimum Order Quantity : 80 shares
Listing At : BSE, NSE

Book running lead managers to the issue are ICICI Securities Limited and Spa Merchant Bankers Ltd.

Registrar of the Issue is Link Intime India Private Ltd Mumbai.

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: